Bioprofarma Bago

Bioprofarma Bagó is a leading Argentine pharmaceutical company specializing in high-complexity treatments, particularly within oncology, hematology, and biotechnology. As a specialized division of the Bagó Group, the company focuses on the development and commercialization of biosimilars and innovative therapies for chronic diseases. Its portfolio includes a wide range of monoclonal antibodies, recombinant proteins, and specialized small molecules designed to treat conditions such as cancer, rheumatoid arthritis, and renal failure. Bioprofarma Bagó is distinguished by its commitment to high-quality manufacturing standards and its role in expanding access to advanced biological therapies in Latin America. The company maintains strategic international partnerships to bring cutting-edge medical solutions to the regional market.